Benzene, an important industrial solvent, is also present in unleaded gasoline and cigarette smoke. The hematotoxic effects of benzene are well documented and include aplastic anemia and pancytopenia. Some individuals exposed repeatedly to cytotoxic concentrations of benzene develop acute myeloblastic anemia. It has been hypothesized that metabolism of benzene is required for its toxicity, although administration of no single benzene metabolite duplicates the toxicity of benzene. Several investigators have demonstrated that a combination of metabolites (hydroquinone and phenol, for example) is necessary to duplicate the hematotoxic effect of benzene. Enzymes implicated in the metabolic activation of benzene and its metabolites include the cytochrome P450 monooxygenases and myeloperoxidase. Since benzene and its hydroxylated metabolites (phenol, hydroquinone, and catechol) are substrates for the same cytochrome P450 enzymes, competitive interactions among the metabolites are possible. In vivo data on metabolite formation by mice exposed to various benzene concentrations are consistent with competitive inhibition of phenol oxidation by benzene. Other organic molecules that are substrates for cytochrome P450 can inhibit the metabolism of benzene. For example, toluene has been shown to inhibit the oxidation of benzene in a noncompetitive manner. Enzyme inducers, such as ethanol, can alter the target tissue dosimetry of benzene metabolites by inducing enzymes responsible for oxidation reactions involved in benzene metabolism. The dosimetry of benzene and its metabolites in the target tissue, bone marrow, depends on the balance of activation processes, such as enzymatic oxidation, and deactivation processes, like conjugation and excretion. Biologically based dosimetry models that incorporate the important determinants of benzene flux, including interactions with other chemicals, will enable prediction of target tissue doses of benzene and metabolites at low exposure concentrations relevant for humans. -Environ Health Perspect 102(Suppl 9):119-124 (1994) 
Introduction
Benzene is a ubiquitous industrial and environmental pollutant (1) . It is present in automobile emissions, both evaporative and combustive, and has been detected in cigarette smoke (2, 3) . Benzene is also commonly used as an industrial solvent in the workplace. Because of its uses in industry and its presence in common human environments, exposure to benzene is most likely associated with co exposure to other volatile organic chemicals normally present in these environments.
Benzene is hematotoxic and carcinogenic at high concentrations. Epidemiology studies have shown that people develop blood dyscrasias, such as pancytopenia, aplastic anemia, and acute myelogenous leukemia following repeated exposure to high concentrations of benzene (4, 5) . In 558-1250. year carcinogenicity studies, rats and mice developed hematotoxicity and tumors in multiple organs, including preputial, Zymbal and Harderian glands, liver, and lymphomas (6) . Benzene also induces chromosomal aberrations and aneuploidy in laboratory animals (7, 8) .
A number of studies have suggested that metabolism of benzene is a key in benzene-induced toxicity (9) (10) (11) . The metabolism of benzene involves a series of oxidations of the benzene ring by the cytochrome P450 monooxygenases. One current hypothesis regarding the role of benzene metabolites in hematotoxicity suggests that following absorption into the blood and translocation to the liver, benzene is metabolized by cytochrome P4502E1 to its major metabolite, phenol ( Figure 1 ) (12) . Phenol can be further oxidized, most likely by the same cytochrome P450, to the polyhydroxylated metabolite, hydroquinone. Alternatively, phenol is sufficiently stable that it can directly partition into the blood and be distributed to other tissues. Similarly, hydroquinone produced from the oxidation of phenol can also partition into the blood. Both phenol and hydroquinone are substrates for phase 2 conjugating enzymes, such as the sulfotransferases and glucuronyl transferases.
Phenyl and hydroquinone sulfates and glucuronides are major metabolites excreted in the urine of animals exposed to benzene (13) . Once in the blood, both phenol and hydroquinone can partition into the bone marrow. Eastmond et al. (10) demonstrated that the myeloperoxidase-dependent metabolism of hydroquinone to the reactive metabolite, benzoquinone, is stimulated by the presence of phenol. Benzoquinone is myelotoxic and clastogenic (14, 15) Figure 2 for benzene concentrations in blood and bone marrow. The similar benzene concentrations for the benzenealone and benzene-toluene groups suggested that coadministration of toluene did not alter the disposition of benzene itself (Figure 2A,B) . In contrast, the concentration of benzene metabolites in tissues of mice given benzene alone were much higher than those found when benzene was coadministered with toluene ( Figure 2C,D) . Coadministration In summary, the observations made in this study, that toluene reduced the level of urinary metabolites of benzene and also reduced the benzene-induced inhibition of erythrocyte 59Fe uptake, suggest that metabolism of benzene is closely related to its hematotoxicity. Inhibition of benzene metabolism by toluene is supported by observations that toluene coexposure markedly reduced bone marrow concentrations of benzene metabolites but had no significant effect on the concentration of benzene in bone marrow. Thus, it seems Single/V 0 hydroquinone were lower in the group exposed to both toluene and benzene compared to the group exposed to benzene alone ( Figure 3 ). The investigators hypothesized that biotransformation of benzene to its hydroxylated metabolites in people is suppressed by coexposure to toluene. These findings suggest that when workers are exposed to toluene in addition to benzene, the amounts of phenol and hydroquinone excreted in urine will be lower than those expected for exposure to only benzene at similar concentrations. These investigators also noted that the formation of hippuric acid and o-cresol from toluene were also reduced by coexposure to benzene; however, the extent of this reduction was not as Hours After End of Exposure Figure 4 . Clearance of benzene and toluene from blood of humans; concentrations of toluene (left) or benzene (right) measured in the blood from human volunteers exposed to 25 ppm benzene and 100 ppm toluene for 2 hr. Squares and solid lines represent blood concentrations of benzene or toluene determined when volunteers were exposed to the single chemical. Circles and dashed lines represent blood concentrations when volunteers were exposed to a mixture. Sato and Nakajima (19) ; reproduced with permission of Toxicology andApplied Pharmacology.
dramatic as the effect of toluene on benzene metabolism. Sato and Nakajima (19) determined the concentrations of benzene and toluene in the blood of humans who inhaled either 25 ppm benzene or 100 ppm toluene or a mixture of benzene and toluene in controlled laboratory experiments for 2 hr (Figure 4) . Their data indicated no difference in the disappearance rate of benzene or toluene from the blood after the end of exposure between the single or combination exposures. These studies with humans exposed to benzene or toluene by inhalation are consistent with the results of Andrews et al. (17) using experimental animals and bolus doses (Figure 2A ). Both studies suggest that while the kinetics of benzene in the blood may be unchanged by coexposure to toluene the formation of the metabolites may be significantly altered by coexposure. The results of both human and animal studies suggest that analysis of metabolite levels may be a more sensitive indicator of interactive effects of benzene and other solvents than analysis of blood or tissue levels of benzene alone.
Alcohol/Benzene Interactions
Consumption of ethanol is an important social factor that might have a considerable impact on the pharmacokinetics and metabolism of benzene. Ethanol is known to induce CYPIIEl, one of the cytochrome P450 enzymes responsible for benzene and phenol metabolism (20, 21) . Studies conducted by Nakajima et al. (22) have shown that pretreatment of rats with ethanol altered the in vitro metabolism of benzene and its major metabolite, phenol. Male Wistar rats were maintained for 3 weeks on a nutritionally adequate liquid diet (basal diet) or an ethanol diet (2 g of ethanol added to 80 ml of basal diet with a reduced sucrose content). At the end of the 3-week period, the animals were either sacrificed to obtain hepatic microsomes for assay of in vitro metabolic activity or were exposed to 500 ppm benzene for 2 hr to determine the clearance of benzene from blood. The in vitro experiments indicated that preexposure to ethanol increased the rate of metabolism of benzene by hepatic microsomes 6-fold and phenol metabolism by 4-fold. Clearance of benzene from the blood following a 2-hr exposure to 500 ppm was significantly faster in the ethanol-treated rats ( Figure 5 ), indicating that for benzene the increased rates of metabolism noted in vitro were reflected in increased rates of benzene clearance in vivo.
Environmental Health Perspectives Presumably, the more rapid clearance of benzene from the blood in the pretreated animals was due to increased metabolism. Previously, Baarson et al. (23) determined that treatment of C57Bl/6J male mice with 5 or 15% ethanol in drinking water increased the hematotoxic effects following 13 weeks of exposure to 300 ppm benzene for 6 hr/day, 5 days/week. Anemia and lymphocytopenia in the peripheral blood and hypocellularity of the bone marrow and spleen were observed in both benzene and ethanol-benzene exposed groups, but were more severe in the ethanol-benzeneexposed groups. These studies are consistent with the results of Nakijima et al. (22) and suggest that ethanol administration, by inducing benzene and phenol metabolism in liver, results in a faster clearance of benzene from blood, and presumably higher concentrations of active metabolites in target tissues. These metabolites, in turn, result in an increased hematotoxicity.
Interacdve Effect ofBenzene and Its Metabolites
Previous studies in laboratory animals exposed to benzene by various routes of administration have demonstrated the dose-dependent metabolism of benzene (13) . For example, in mice exposed to benzene by gavage, there is a decrease in the percent of the total amount of urinary metabolites eliminated as hydroquinone 
